Sponsor:
University of Texas at Austin
Code:
NCT07074912
Conditions
Fever
Eligibility Criteria
Sex: All
Age: 0 - 3
Healthy Volunteers: Not accepted
Interventions
Prescription for weight-based dosing of antipyretic
Standard discharge instructions
Brief summary:
Conditions
Fever
Study ID
NCT07074912
Start date
Dec 15, 2024
Status verified date
Jul, 2025
Completion date
Mar 15, 2026
Anticipated
Primary completion date
Dec 31, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 3
Healthy Volunteers: Not accepted
Enrollment
440 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Prescription for weight-based dosing of antipyretic
active comparator: Standard discharge instructions
Interventions
Prescription for weight-based dosing of antipyretic
Standard discharge instructions
Primary outcome measure
Central contacts
Locations
Dell Children's Medical Center
Recruiting
Austin, Texas, United States, 78723
Contacts
Principal Investigator:
Bradley Yingst, DO
Sponsor
University of Texas at Austin
Last update posted
Jul 20, 2025
Last verified
Jul, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Texas at Austin on 2025-07-20.